id	sid	tid	token	lemma	pos
dpc-3923	1	1	dermatology	dermatology	NOUN
dpc-3923	1	2	:	:	PUNCT
dpc-3923	1	3	practical	practical	ADJ
dpc-3923	1	4	and	and	CCONJ
dpc-3923	1	5	conceptual	conceptual	ADJ
dpc-3923	1	6	image	image	NOUN
dpc-3923	1	7	letter	letter	NOUN
dpc-3923	2	1	|	|	ADV
dpc-3923	2	2	dermatol	dermatol	ADJ
dpc-3923	2	3	pract	pract	NOUN
dpc-3923	2	4	concept	concept	NOUN
dpc-3923	2	5	.	.	PUNCT
dpc-3923	3	1	2024;14(2):e2024082	2024;14(2):e2024082	NUM
dpc-3923	3	2	1	1	NUM
dpc-3923	3	3	nilotinib	nilotinib	NOUN
dpc-3923	3	4	induced	induce	VERB
dpc-3923	3	5	keratosis	keratosis	NOUN
dpc-3923	3	6	pilaris	pilaris	NOUN
dpc-3923	3	7	in	in	ADP
dpc-3923	3	8	a	a	DET
dpc-3923	3	9	female	female	NOUN
dpc-3923	3	10	with	with	ADP
dpc-3923	3	11	chronic	chronic	ADJ
dpc-3923	3	12	myeloid	myeloid	NOUN
dpc-3923	3	13	leukemia	leukemia	PROPN
dpc-3923	3	14	ranjana	ranjana	PROPN
dpc-3923	3	15	beniwal1	beniwal1	NOUN
dpc-3923	3	16	,	,	PUNCT
dpc-3923	3	17	akriti	akriti	ADV
dpc-3923	3	18	agrawal2	agrawal2	PROPN
dpc-3923	4	1	1	1	NUM
dpc-3923	4	2	dr	dr	PROPN
dpc-3923	4	3	.	.	PROPN
dpc-3923	4	4	sampurnanand	sampurnanand	PROPN
dpc-3923	4	5	medical	medical	PROPN
dpc-3923	4	6	college	college	PROPN
dpc-3923	4	7	and	and	CCONJ
dpc-3923	4	8	associated	associated	ADJ
dpc-3923	4	9	group	group	NOUN
dpc-3923	4	10	of	of	ADP
dpc-3923	4	11	hospitals	hospital	NOUN
dpc-3923	4	12	,	,	PUNCT
dpc-3923	4	13	jodhpur	jodhpur	PROPN
dpc-3923	4	14	,	,	PUNCT
dpc-3923	4	15	india	india	PROPN
dpc-3923	4	16	2	2	NUM
dpc-3923	4	17	department	department	NOUN
dpc-3923	4	18	of	of	ADP
dpc-3923	4	19	dermatology	dermatology	NOUN
dpc-3923	4	20	,	,	PUNCT
dpc-3923	4	21	jawaharlal	jawaharlal	PROPN
dpc-3923	4	22	institute	institute	PROPN
dpc-3923	4	23	of	of	ADP
dpc-3923	4	24	postgraduate	postgraduate	PROPN
dpc-3923	4	25	medical	medical	ADJ
dpc-3923	4	26	education	education	NOUN
dpc-3923	4	27	and	and	CCONJ
dpc-3923	4	28	research	research	NOUN
dpc-3923	4	29	 	 	SPACE
dpc-3923	4	30	(	(	PUNCT
dpc-3923	4	31	jipmer	jipmer	PROPN
dpc-3923	4	32	)	)	PUNCT
dpc-3923	4	33	,	,	PUNCT
dpc-3923	4	34	puducherry	puducherry	PROPN
dpc-3923	4	35	,	,	PUNCT
dpc-3923	4	36	india	india	PROPN
dpc-3923	4	37	citation	citation	PROPN
dpc-3923	4	38	:	:	PUNCT
dpc-3923	4	39	beniwal	beniwal	NOUN
dpc-3923	4	40	r	r	NOUN
dpc-3923	4	41	,	,	PUNCT
dpc-3923	4	42	agrawal	agrawal	PROPN
dpc-3923	4	43	a.	a.	NOUN
dpc-3923	4	44	nilotinib	nilotinib	NOUN
dpc-3923	4	45	induced	induce	VERB
dpc-3923	4	46	keratosis	keratosis	NOUN
dpc-3923	4	47	pilaris	pilaris	NOUN
dpc-3923	4	48	in	in	ADP
dpc-3923	4	49	a	a	DET
dpc-3923	4	50	female	female	NOUN
dpc-3923	4	51	with	with	ADP
dpc-3923	4	52	chronic	chronic	ADJ
dpc-3923	4	53	myeloid	myeloid	NOUN
dpc-3923	4	54	leukemia	leukemia	NOUN
dpc-3923	4	55	.	.	PUNCT
dpc-3923	5	1	dermatol	dermatol	NOUN
dpc-3923	5	2	pract	pract	PROPN
dpc-3923	5	3	concept	concept	NOUN
dpc-3923	5	4	.	.	PUNCT
dpc-3923	6	1	2024;14(2):e2024082	2024;14(2):e2024082	X
dpc-3923	6	2	.	.	PUNCT
dpc-3923	7	1	doi	doi	PROPN
dpc-3923	7	2	:	:	PUNCT
dpc-3923	7	3	https://doi.org/10.5826/dpc.1402a82	https://doi.org/10.5826/dpc.1402a82	NOUN
dpc-3923	7	4	accepted	accept	VERB
dpc-3923	7	5	:	:	PUNCT
dpc-3923	7	6	october	october	PROPN
dpc-3923	7	7	30	30	NUM
dpc-3923	7	8	,	,	PUNCT
dpc-3923	7	9	2023	2023	NUM
dpc-3923	7	10	;	;	PUNCT
dpc-3923	7	11	published	publish	VERB
dpc-3923	7	12	:	:	PUNCT
dpc-3923	8	1	april	april	PROPN
dpc-3923	8	2	2024	2024	NUM
dpc-3923	8	3	copyright	copyright	NOUN
dpc-3923	8	4	:	:	PUNCT
dpc-3923	8	5	©	©	PROPN
dpc-3923	8	6	2024	2024	NUM
dpc-3923	8	7	beniwal	beniwal	NOUN
dpc-3923	8	8	et	et	NOUN
dpc-3923	8	9	al	al	PROPN
dpc-3923	8	10	.	.	PUNCT
dpc-3923	9	1	this	this	PRON
dpc-3923	9	2	is	be	AUX
dpc-3923	9	3	an	an	DET
dpc-3923	9	4	open	open	ADJ
dpc-3923	9	5	-	-	PUNCT
dpc-3923	9	6	access	access	NOUN
dpc-3923	9	7	article	article	NOUN
dpc-3923	9	8	distributed	distribute	VERB
dpc-3923	9	9	under	under	ADP
dpc-3923	9	10	the	the	DET
dpc-3923	9	11	terms	term	NOUN
dpc-3923	9	12	of	of	ADP
dpc-3923	9	13	the	the	DET
dpc-3923	9	14	creative	creative	ADJ
dpc-3923	9	15	commons	common	NOUN
dpc-3923	9	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-3923	9	17	license	license	NOUN
dpc-3923	9	18	(	(	PUNCT
dpc-3923	9	19	by	by	ADP
dpc-3923	9	20	-	-	PUNCT
dpc-3923	9	21	nc-4.0	nc-4.0	NOUN
dpc-3923	9	22	)	)	PUNCT
dpc-3923	9	23	,	,	PUNCT
dpc-3923	9	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-3923	9	25	,	,	PUNCT
dpc-3923	9	26	which	which	PRON
dpc-3923	9	27	permits	permit	VERB
dpc-3923	9	28	unrestricted	unrestricted	ADJ
dpc-3923	9	29	noncommercial	noncommercial	ADJ
dpc-3923	9	30	use	use	NOUN
dpc-3923	9	31	,	,	PUNCT
dpc-3923	9	32	distribution	distribution	NOUN
dpc-3923	9	33	,	,	PUNCT
dpc-3923	9	34	and	and	CCONJ
dpc-3923	9	35	reproduction	reproduction	NOUN
dpc-3923	9	36	in	in	ADP
dpc-3923	9	37	any	any	DET
dpc-3923	9	38	medium	medium	NOUN
dpc-3923	9	39	,	,	PUNCT
dpc-3923	9	40	provided	provide	VERB
dpc-3923	9	41	the	the	DET
dpc-3923	9	42	original	original	ADJ
dpc-3923	9	43	authors	author	NOUN
dpc-3923	9	44	and	and	CCONJ
dpc-3923	9	45	source	source	NOUN
dpc-3923	9	46	are	be	AUX
dpc-3923	9	47	credited	credit	VERB
dpc-3923	9	48	.	.	PUNCT
dpc-3923	10	1	funding	funding	NOUN
dpc-3923	10	2	:	:	PUNCT
dpc-3923	10	3	none	none	NOUN
dpc-3923	10	4	.	.	PUNCT
dpc-3923	11	1	competing	compete	VERB
dpc-3923	11	2	interests	interest	NOUN
dpc-3923	11	3	:	:	PUNCT
dpc-3923	11	4	none	none	NOUN
dpc-3923	11	5	.	.	PUNCT
dpc-3923	12	1	authorship	authorship	NOUN
dpc-3923	12	2	:	:	PUNCT
dpc-3923	12	3	both	both	CCONJ
dpc-3923	12	4	the	the	DET
dpc-3923	12	5	authors	author	NOUN
dpc-3923	12	6	have	have	AUX
dpc-3923	12	7	contributed	contribute	VERB
dpc-3923	12	8	significantly	significantly	ADV
dpc-3923	12	9	to	to	ADP
dpc-3923	12	10	this	this	DET
dpc-3923	12	11	publication	publication	NOUN
dpc-3923	12	12	.	.	PUNCT
dpc-3923	13	1	corresponding	correspond	VERB
dpc-3923	13	2	author	author	NOUN
dpc-3923	13	3	:	:	PUNCT
dpc-3923	13	4	ranjana	ranjana	PROPN
dpc-3923	13	5	beniwal	beniwal	PROPN
dpc-3923	13	6	m.d	m.d	PROPN
dpc-3923	13	7	.	.	PROPN
dpc-3923	13	8	,	,	PUNCT
dpc-3923	13	9	consultant	consultant	NOUN
dpc-3923	13	10	dermatologist	dermatologist	NOUN
dpc-3923	13	11	,	,	PUNCT
dpc-3923	13	12	department	department	NOUN
dpc-3923	13	13	of	of	ADP
dpc-3923	13	14	dermatology	dermatology	NOUN
dpc-3923	13	15	,	,	PUNCT
dpc-3923	13	16	venereology	venereology	NOUN
dpc-3923	13	17	and	and	CCONJ
dpc-3923	13	18	leprology	leprology	NOUN
dpc-3923	13	19	,	,	PUNCT
dpc-3923	13	20	dr	dr	PROPN
dpc-3923	13	21	.	.	PROPN
dpc-3923	13	22	 	 	SPACE
dpc-3923	13	23	sampurnanand	sampurnanand	PROPN
dpc-3923	13	24	medical	medical	PROPN
dpc-3923	13	25	college	college	PROPN
dpc-3923	13	26	and	and	CCONJ
dpc-3923	13	27	associated	associated	ADJ
dpc-3923	13	28	group	group	NOUN
dpc-3923	13	29	of	of	ADP
dpc-3923	13	30	hospitals	hospital	NOUN
dpc-3923	13	31	,	,	PUNCT
dpc-3923	13	32	jodhpur	jodhpur	PROPN
dpc-3923	13	33	,	,	PUNCT
dpc-3923	13	34	india	india	PROPN
dpc-3923	13	35	.	.	PUNCT
dpc-3923	13	36	email	email	NOUN
dpc-3923	13	37	:	:	PUNCT
dpc-3923	13	38	 	 	SPACE
dpc-3923	13	39	ranjanabeniwal@gmail.com	ranjanabeniwal@gmail.com	NOUN
dpc-3923	14	1	case	case	NOUN
dpc-3923	14	2	presentation	presentation	NOUN
dpc-3923	14	3	a	a	DET
dpc-3923	14	4	34	34	NUM
dpc-3923	14	5	-	-	PUNCT
dpc-3923	14	6	year	year	NOUN
dpc-3923	14	7	old	old	ADJ
dpc-3923	14	8	female	female	NOUN
dpc-3923	14	9	on	on	ADP
dpc-3923	14	10	nilotinib	nilotinib	NOUN
dpc-3923	14	11	200	200	NUM
dpc-3923	14	12	mg	mg	NOUN
dpc-3923	14	13	twice	twice	ADV
dpc-3923	14	14	daily	daily	ADV
dpc-3923	14	15	for	for	ADP
dpc-3923	14	16	chronic	chronic	ADJ
dpc-3923	14	17	myeloid	myeloid	NOUN
dpc-3923	14	18	leukemia	leukemia	PROPN
dpc-3923	14	19	presented	present	VERB
dpc-3923	14	20	with	with	ADP
dpc-3923	14	21	multiple	multiple	ADJ
dpc-3923	14	22	asymptomatic	asymptomatic	ADJ
dpc-3923	14	23	gradually	gradually	ADV
dpc-3923	14	24	progressive	progressive	ADJ
dpc-3923	14	25	raised	raise	VERB
dpc-3923	14	26	lesions	lesion	NOUN
dpc-3923	14	27	over	over	ADP
dpc-3923	14	28	body	body	NOUN
dpc-3923	14	29	for	for	ADP
dpc-3923	14	30	four	four	NUM
dpc-3923	14	31	years	year	NOUN
dpc-3923	14	32	.	.	PUNCT
dpc-3923	15	1	she	she	PRON
dpc-3923	15	2	was	be	AUX
dpc-3923	15	3	not	not	PART
dpc-3923	15	4	on	on	ADP
dpc-3923	15	5	any	any	DET
dpc-3923	15	6	other	other	ADJ
dpc-3923	15	7	medications	medication	NOUN
dpc-3923	15	8	and	and	CCONJ
dpc-3923	15	9	developed	develop	VERB
dpc-3923	15	10	the	the	DET
dpc-3923	15	11	lesions	lesion	NOUN
dpc-3923	15	12	a	a	DET
dpc-3923	15	13	few	few	ADJ
dpc-3923	15	14	weeks	week	NOUN
dpc-3923	15	15	after	after	ADP
dpc-3923	15	16	starting	start	VERB
dpc-3923	15	17	nilotinib	nilotinib	NOUN
dpc-3923	15	18	.	.	PUNCT
dpc-3923	16	1	examination	examination	NOUN
dpc-3923	16	2	revealed	reveal	VERB
dpc-3923	16	3	skin	skin	NOUN
dpc-3923	16	4	-	-	PUNCT
dpc-3923	16	5	colored	color	VERB
dpc-3923	16	6	-	-	PUNCT
dpc-3923	16	7	to	to	ADP
dpc-3923	16	8	-	-	PUNCT
dpc-3923	16	9	erythematous	erythematous	ADJ
dpc-3923	16	10	follicular	follicular	ADJ
dpc-3923	16	11	hyperkeratotic	hyperkeratotic	ADJ
dpc-3923	16	12	papules	papule	NOUN
dpc-3923	16	13	over	over	ADP
dpc-3923	16	14	face	face	NOUN
dpc-3923	16	15	,	,	PUNCT
dpc-3923	16	16	trunk	trunk	NOUN
dpc-3923	16	17	,	,	PUNCT
dpc-3923	16	18	and	and	CCONJ
dpc-3923	16	19	bilateral	bilateral	ADJ
dpc-3923	16	20	upper	upper	ADJ
dpc-3923	16	21	and	and	CCONJ
dpc-3923	16	22	lower	low	ADJ
dpc-3923	16	23	limbs	limb	NOUN
dpc-3923	16	24	.	.	PUNCT
dpc-3923	17	1	routine	routine	ADJ
dpc-3923	17	2	investigations	investigation	NOUN
dpc-3923	17	3	were	be	AUX
dpc-3923	17	4	within	within	ADP
dpc-3923	17	5	normal	normal	ADJ
dpc-3923	17	6	limits	limit	NOUN
dpc-3923	17	7	.	.	PUNCT
dpc-3923	18	1	histopathology	histopathology	NOUN
dpc-3923	18	2	showed	show	VERB
dpc-3923	18	3	orthokeratosis	orthokeratosis	NOUN
dpc-3923	18	4	,	,	PUNCT
dpc-3923	18	5	follicular	follicular	ADJ
dpc-3923	18	6	plugging	plugging	NOUN
dpc-3923	18	7	with	with	ADP
dpc-3923	18	8	perifollicular	perifollicular	ADJ
dpc-3923	18	9	fibrosis	fibrosis	NOUN
dpc-3923	18	10	,	,	PUNCT
dpc-3923	18	11	and	and	CCONJ
dpc-3923	18	12	a	a	DET
dpc-3923	18	13	mild	mild	ADJ
dpc-3923	18	14	lymphocytic	lymphocytic	ADJ
dpc-3923	18	15	inflammatory	inflammatory	ADJ
dpc-3923	18	16	infiltrate	infiltrate	NOUN
dpc-3923	18	17	.	.	PUNCT
dpc-3923	19	1	based	base	VERB
dpc-3923	19	2	on	on	ADP
dpc-3923	19	3	temporal	temporal	ADJ
dpc-3923	19	4	correlation	correlation	NOUN
dpc-3923	19	5	with	with	ADP
dpc-3923	19	6	drug	drug	NOUN
dpc-3923	19	7	intake	intake	NOUN
dpc-3923	19	8	and	and	CCONJ
dpc-3923	19	9	inexplicability	inexplicability	NOUN
dpc-3923	19	10	of	of	ADP
dpc-3923	19	11	occurrence	occurrence	NOUN
dpc-3923	19	12	of	of	ADP
dpc-3923	19	13	the	the	DET
dpc-3923	19	14	eruption	eruption	NOUN
dpc-3923	19	15	due	due	ADP
dpc-3923	19	16	to	to	ADP
dpc-3923	19	17	disease	disease	NOUN
dpc-3923	19	18	or	or	CCONJ
dpc-3923	19	19	other	other	ADJ
dpc-3923	19	20	drugs	drug	NOUN
dpc-3923	19	21	,	,	PUNCT
dpc-3923	19	22	it	it	PRON
dpc-3923	19	23	was	be	AUX
dpc-3923	19	24	diagnosed	diagnose	VERB
dpc-3923	19	25	as	as	ADP
dpc-3923	19	26	a	a	DET
dpc-3923	19	27	case	case	NOUN
dpc-3923	19	28	of	of	ADP
dpc-3923	19	29	nilotinib	nilotinib	NOUN
dpc-3923	19	30	-	-	PUNCT
dpc-3923	19	31	induced	induce	VERB
dpc-3923	19	32	keratosis	keratosis	NOUN
dpc-3923	19	33	pilaris	pilaris	NOUN
dpc-3923	19	34	.	.	PUNCT
dpc-3923	20	1	teaching	teaching	NOUN
dpc-3923	20	2	point	point	NOUN
dpc-3923	20	3	nilotinib	nilotinib	NOUN
dpc-3923	20	4	is	be	AUX
dpc-3923	20	5	a	a	DET
dpc-3923	20	6	second	second	ADJ
dpc-3923	20	7	-	-	PUNCT
dpc-3923	20	8	generation	generation	NOUN
dpc-3923	20	9	bcr	bcr	ADJ
dpc-3923	20	10	-	-	ADJ
dpc-3923	20	11	abl	abl	PROPN
dpc-3923	20	12	tyrosine	tyrosine	PROPN
dpc-3923	20	13	kinase	kinase	PROPN
dpc-3923	20	14	inhibitor	inhibitor	PROPN
dpc-3923	20	15	(	(	PUNCT
dpc-3923	20	16	tki	tki	NOUN
dpc-3923	20	17	)	)	PUNCT
dpc-3923	21	1	[	[	X
dpc-3923	21	2	1	1	NUM
dpc-3923	21	3	]	]	PUNCT
dpc-3923	21	4	.	.	PUNCT
dpc-3923	22	1	the	the	DET
dpc-3923	22	2	various	various	ADJ
dpc-3923	22	3	cutaneous	cutaneous	ADJ
dpc-3923	22	4	adverse	adverse	ADJ
dpc-3923	22	5	effects	effect	NOUN
dpc-3923	22	6	of	of	ADP
dpc-3923	22	7	tkis	tkis	NOUN
dpc-3923	22	8	include	include	VERB
dpc-3923	22	9	alopecia	alopecia	NOUN
dpc-3923	22	10	,	,	PUNCT
dpc-3923	22	11	xerosis	xerosis	NOUN
dpc-3923	22	12	,	,	PUNCT
dpc-3923	22	13	maculopapular	maculopapular	ADJ
dpc-3923	22	14	rash	rash	NOUN
dpc-3923	22	15	,	,	PUNCT
dpc-3923	22	16	photosensitivity	photosensitivity	NOUN
dpc-3923	22	17	,	,	PUNCT
dpc-3923	22	18	hypopigmentation	hypopigmentation	NOUN
dpc-3923	22	19	,	,	PUNCT
dpc-3923	22	20	and	and	CCONJ
dpc-3923	22	21	edema	edema	NOUN
dpc-3923	22	22	.	.	PUNCT
dpc-3923	23	1	keratosis	keratosis	NOUN
dpc-3923	23	2	pilaris	pilaris	NOUN
dpc-3923	23	3	like	like	ADP
dpc-3923	23	4	eruption	eruption	NOUN
dpc-3923	23	5	has	have	AUX
dpc-3923	23	6	been	be	AUX
dpc-3923	23	7	reported	report	VERB
dpc-3923	23	8	with	with	ADP
dpc-3923	23	9	the	the	DET
dpc-3923	23	10	more	more	ADV
dpc-3923	23	11	potent	potent	ADJ
dpc-3923	23	12	second	second	ADJ
dpc-3923	23	13	and	and	CCONJ
dpc-3923	23	14	third	third	ADJ
dpc-3923	23	15	generation	generation	NOUN
dpc-3923	23	16	multitargeted	multitargete	VERB
dpc-3923	23	17	tkis	tkis	NOUN
dpc-3923	23	18	like	like	ADP
dpc-3923	23	19	nilotinib	nilotinib	NOUN
dpc-3923	23	20	,	,	PUNCT
dpc-3923	23	21	dasatinib	dasatinib	NOUN
dpc-3923	23	22	,	,	PUNCT
dpc-3923	23	23	and	and	CCONJ
dpc-3923	23	24	posatinib	posatinib	NOUN
dpc-3923	23	25	and	and	CCONJ
dpc-3923	23	26	is	be	AUX
dpc-3923	23	27	attributed	attribute	VERB
dpc-3923	23	28	to	to	ADP
dpc-3923	23	29	their	their	PRON
dpc-3923	23	30	expanded	expand	VERB
dpc-3923	23	31	spectrum	spectrum	NOUN
dpc-3923	23	32	of	of	ADP
dpc-3923	23	33	activity	activity	NOUN
dpc-3923	23	34	against	against	ADP
dpc-3923	23	35	related	related	ADJ
dpc-3923	23	36	kinase	kinase	NOUN
dpc-3923	23	37	targets	target	NOUN
dpc-3923	23	38	other	other	ADJ
dpc-3923	23	39	than	than	ADP
dpc-3923	23	40	bcr	bcr	PROPN
dpc-3923	23	41	-	-	PROPN
dpc-3923	23	42	abl	abl	NOUN
dpc-3923	24	1	[	[	X
dpc-3923	24	2	2	2	NUM
dpc-3923	24	3	]	]	PUNCT
dpc-3923	24	4	.	.	PUNCT
dpc-3923	25	1	the	the	DET
dpc-3923	25	2	rash	rash	NOUN
dpc-3923	25	3	is	be	AUX
dpc-3923	25	4	usually	usually	ADV
dpc-3923	25	5	asymptomatic	asymptomatic	ADJ
dpc-3923	25	6	2	2	NUM
dpc-3923	25	7	image	image	NOUN
dpc-3923	25	8	letter	letter	NOUN
dpc-3923	25	9	|	|	ADV
dpc-3923	25	10	dermatol	dermatol	ADJ
dpc-3923	25	11	pract	pract	NOUN
dpc-3923	25	12	concept	concept	NOUN
dpc-3923	25	13	.	.	PUNCT
dpc-3923	26	1	2024;14(2):e2024082	2024;14(2):e2024082	NUM
dpc-3923	26	2	or	or	CCONJ
dpc-3923	26	3	pruritic	pruritic	ADJ
dpc-3923	26	4	and	and	CCONJ
dpc-3923	26	5	characterized	characterize	VERB
dpc-3923	26	6	by	by	ADP
dpc-3923	26	7	a	a	DET
dpc-3923	26	8	generalized	generalized	ADJ
dpc-3923	26	9	distribution	distribution	NOUN
dpc-3923	26	10	on	on	ADP
dpc-3923	26	11	the	the	DET
dpc-3923	26	12	face	face	NOUN
dpc-3923	26	13	,	,	PUNCT
dpc-3923	26	14	trunk	trunk	NOUN
dpc-3923	26	15	,	,	PUNCT
dpc-3923	26	16	and	and	CCONJ
dpc-3923	26	17	extremities	extremity	NOUN
dpc-3923	26	18	.	.	PUNCT
dpc-3923	27	1	it	it	PRON
dpc-3923	27	2	typically	typically	ADV
dpc-3923	27	3	starts	start	VERB
dpc-3923	27	4	several	several	ADJ
dpc-3923	27	5	weeks	week	NOUN
dpc-3923	27	6	after	after	ADP
dpc-3923	27	7	initiation	initiation	NOUN
dpc-3923	27	8	of	of	ADP
dpc-3923	27	9	the	the	DET
dpc-3923	27	10	drug	drug	NOUN
dpc-3923	27	11	and	and	CCONJ
dpc-3923	27	12	is	be	AUX
dpc-3923	27	13	not	not	PART
dpc-3923	27	14	dose	dose	NOUN
dpc-3923	27	15	-	-	PUNCT
dpc-3923	27	16	dependent	dependent	ADJ
dpc-3923	27	17	.	.	PUNCT
dpc-3923	28	1	currently	currently	ADV
dpc-3923	28	2	,	,	PUNCT
dpc-3923	28	3	there	there	PRON
dpc-3923	28	4	is	be	VERB
dpc-3923	28	5	no	no	DET
dpc-3923	28	6	consensus	consensus	NOUN
dpc-3923	28	7	regarding	regard	VERB
dpc-3923	28	8	treatment	treatment	NOUN
dpc-3923	28	9	of	of	ADP
dpc-3923	28	10	keratosis	keratosis	NOUN
dpc-3923	28	11	pilaris	pilaris	NOUN
dpc-3923	28	12	-	-	PUNCT
dpc-3923	28	13	like	like	ADJ
dpc-3923	28	14	eruption	eruption	NOUN
dpc-3923	28	15	induced	induce	VERB
dpc-3923	28	16	by	by	ADP
dpc-3923	28	17	nilotinib	nilotinib	NOUN
dpc-3923	28	18	.	.	PUNCT
dpc-3923	29	1	the	the	DET
dpc-3923	29	2	rash	rash	NOUN
dpc-3923	29	3	is	be	AUX
dpc-3923	29	4	usually	usually	ADV
dpc-3923	29	5	refractory	refractory	ADJ
dpc-3923	29	6	to	to	ADP
dpc-3923	29	7	treatment	treatment	NOUN
dpc-3923	29	8	in	in	ADP
dpc-3923	29	9	the	the	DET
dpc-3923	29	10	majority	majority	NOUN
dpc-3923	29	11	of	of	ADP
dpc-3923	29	12	cases	case	NOUN
dpc-3923	29	13	and	and	CCONJ
dpc-3923	29	14	may	may	AUX
dpc-3923	29	15	resolve	resolve	VERB
dpc-3923	29	16	partially	partially	ADV
dpc-3923	29	17	or	or	CCONJ
dpc-3923	29	18	completely	completely	ADV
dpc-3923	29	19	after	after	ADP
dpc-3923	29	20	withdrawal	withdrawal	NOUN
dpc-3923	29	21	of	of	ADP
dpc-3923	29	22	the	the	DET
dpc-3923	29	23	treatment	treatment	NOUN
dpc-3923	29	24	.	.	PUNCT
dpc-3923	30	1	references	reference	NOUN
dpc-3923	30	2	1	1	NUM
dpc-3923	30	3	.	.	PUNCT
dpc-3923	30	4	jabbour	jabbour	PROPN
dpc-3923	30	5	e	e	PROPN
dpc-3923	30	6	,	,	PUNCT
dpc-3923	30	7	cortes	corte	VERB
dpc-3923	30	8	j	j	PROPN
dpc-3923	30	9	,	,	PUNCT
dpc-3923	30	10	kantarjian	kantarjian	ADJ
dpc-3923	30	11	h.	h.	PROPN
dpc-3923	30	12	treatment	treatment	NOUN
dpc-3923	30	13	selection	selection	NOUN
dpc-3923	30	14	after	after	ADP
dpc-3923	30	15	imatinib	imatinib	NOUN
dpc-3923	30	16	resistance	resistance	NOUN
dpc-3923	30	17	in	in	ADP
dpc-3923	30	18	chronic	chronic	ADJ
dpc-3923	30	19	myeloid	myeloid	NOUN
dpc-3923	30	20	leukemia	leukemia	NOUN
dpc-3923	30	21	.	.	PUNCT
dpc-3923	30	22	 	 	SPACE
dpc-3923	31	1	target	target	VERB
dpc-3923	31	2	oncol	oncol	ADJ
dpc-3923	31	3	.	.	PUNCT
dpc-3923	32	1	2009;4(1):3	2009;4(1):3	PROPN
dpc-3923	32	2	-	-	PUNCT
dpc-3923	32	3	10	10	NUM
dpc-3923	32	4	.	.	PUNCT
dpc-3923	32	5	doi:10.1007	doi:10.1007	VERB
dpc-3923	32	6	/	/	SYM
dpc-3923	32	7	s11523	s11523	NOUN
dpc-3923	32	8	-	-	PUNCT
dpc-3923	32	9	008	008	NUM
dpc-3923	32	10	-	-	PUNCT
dpc-3923	32	11	0100	0100	NUM
dpc-3923	32	12	-	-	PUNCT
dpc-3923	32	13	y	y	PROPN
dpc-3923	32	14	2	2	NUM
dpc-3923	32	15	.	.	PUNCT
dpc-3923	32	16	delgado	delgado	NOUN
dpc-3923	32	17	l	l	NOUN
dpc-3923	32	18	,	,	PUNCT
dpc-3923	32	19	giraudier	giraudier	NOUN
dpc-3923	32	20	s	s	PROPN
dpc-3923	32	21	,	,	PUNCT
dpc-3923	32	22	ortonne	ortonne	NOUN
dpc-3923	32	23	n	n	CCONJ
dpc-3923	32	24	,	,	PUNCT
dpc-3923	32	25	et	et	PROPN
dpc-3923	32	26	al	al	PROPN
dpc-3923	32	27	.	.	PROPN
dpc-3923	33	1	adverse	adverse	ADJ
dpc-3923	33	2	cutaneous	cutaneous	ADJ
dpc-3923	33	3	reactions	reaction	NOUN
dpc-3923	33	4	to	to	ADP
dpc-3923	33	5	the	the	DET
dpc-3923	33	6	new	new	ADJ
dpc-3923	33	7	second	second	ADJ
dpc-3923	33	8	-	-	PUNCT
dpc-3923	33	9	generation	generation	NOUN
dpc-3923	33	10	tyrosine	tyrosine	NOUN
dpc-3923	33	11	kinase	kinase	PROPN
dpc-3923	33	12	inhibitors	inhibitor	NOUN
dpc-3923	33	13	(	(	PUNCT
dpc-3923	33	14	dasatinib	dasatinib	NOUN
dpc-3923	33	15	,	,	PUNCT
dpc-3923	33	16	nilotinib	nilotinib	NOUN
dpc-3923	33	17	)	)	PUNCT
dpc-3923	33	18	in	in	ADP
dpc-3923	33	19	chronic	chronic	ADJ
dpc-3923	33	20	myeloid	myeloid	NOUN
dpc-3923	33	21	leukemia	leukemia	NOUN
dpc-3923	33	22	.	.	PUNCT
dpc-3923	33	23	  	  	SPACE
dpc-3923	34	1	j	j	PROPN
dpc-3923	34	2	am	be	AUX
dpc-3923	34	3	acad	acad	ADJ
dpc-3923	34	4	dermatol	dermatol	NOUN
dpc-3923	34	5	.	.	PUNCT
dpc-3923	35	1	2013;69(5):839	2013;69(5):839	PROPN
dpc-3923	35	2	-	-	PUNCT
dpc-3923	35	3	840	840	NUM
dpc-3923	35	4	.	.	PUNCT
dpc-3923	36	1	doi:10.1016	doi:10.1016	PROPN
dpc-3923	36	2	/	/	SYM
dpc-3923	36	3	j.jaad.2013.07.025	j.jaad.2013.07.025	PROPN
dpc-3923	36	4	figure	figure	VERB
dpc-3923	36	5	1	1	NUM
dpc-3923	36	6	.	.	PUNCT
dpc-3923	37	1	multiple	multiple	ADJ
dpc-3923	37	2	follicular	follicular	ADJ
dpc-3923	37	3	keratotic	keratotic	ADJ
dpc-3923	37	4	papules	papule	NOUN
dpc-3923	37	5	present	present	ADJ
dpc-3923	37	6	over	over	ADP
dpc-3923	37	7	face	face	NOUN
dpc-3923	37	8	(	(	PUNCT
dpc-3923	37	9	a	a	X
dpc-3923	37	10	)	)	PUNCT
dpc-3923	37	11	,	,	PUNCT
dpc-3923	37	12	trunk	trunk	NOUN
dpc-3923	37	13	(	(	PUNCT
dpc-3923	37	14	b	b	NOUN
dpc-3923	37	15	)	)	PUNCT
dpc-3923	37	16	,	,	PUNCT
dpc-3923	37	17	upper	upper	ADJ
dpc-3923	37	18	arm	arm	NOUN
dpc-3923	37	19	,	,	PUNCT
dpc-3923	37	20	(	(	PUNCT
dpc-3923	37	21	c	c	NOUN
dpc-3923	37	22	)	)	PUNCT
dpc-3923	37	23	and	and	CCONJ
dpc-3923	37	24	thighs	thigh	NOUN
dpc-3923	37	25	(	(	PUNCT
dpc-3923	37	26	d	d	NOUN
dpc-3923	37	27	)	)	PUNCT
dpc-3923	37	28	.	.	PUNCT